Where a National Institute for Health and Clinical Excellence (NICE) Multiple Technology Appraisal (MTA) supersedes a recommendation from the Scottish Medicines Consortium (SMC), patients in Scotland already receiving the drug in question would not have it withdrawn unless there was a clinical reason to do so. However, clinicians, in taking account of the N...